INO
Inovio Pharmaceuticals Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Inovio Pharmaceuticals is a biotechnology company specializing in the development of gene therapies to treat cancer and infectious diseases.
Inovio Pharmaceuticals Inc
INO
Inovio Pharmaceuticals is a biotechnology company specializing in the development of gene therapies to treat cancer and infectious diseases.
Price history of Inovio Pharmaceuticals Inc
Price history of Inovio Pharmaceuticals Inc
Performance & Momentum
Strategic Analysis
Inovio Pharmaceuticals Inc • 2026
Inovio Pharmaceuticals positions itself as an innovative player in the U.S. biotechnology sector, focused on developing gene therapies targeting cancer and infectious diseases. Its business model is based on high-potential disruptive technologies in oncology, aiming to capitalize on unmet medical needs.
- Strong expertise in gene therapies with a focus on oncology
- High potential tied to scientific innovation in a rapidly expanding sector
- Positioning in strategic and promising therapeutic niches
- Very poor historical stock performance over the medium and long term
- Lack of recent positive news to bolster investor confidence
The current momentum indicates a moderate resurgence in interest, which may reflect the beginning of stabilization after a long period of decline. However, the absence of recent catalysts warrants caution and vigilance in the short-term valuation.
Similar stocks to Inovio Pharmaceuticals Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
